After 'reset,' Flagship startup lands $1.8B Bristol Myers Squibb deal



The biotech is forging ahead 18 months after scrapping its two lead drugs and laying off 65 workers.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *